Oriza Holdings

Oriza Holdings is an asset management firm based in Suzhou, China, founded in 2001. The company specializes in providing equity and debt financing solutions to companies at various stages of development, from seed to growth stages. Oriza Holdings operates through multiple investment arms, focusing on sectors such as industrial, healthcare, integrated circuits, and technology, media, and telecommunications (TMT). The company also has a professional platform for mergers and acquisitions, known as Oriza Prior, which integrates investment and industrial resources to enhance operational efficiency and maximize investment returns. With a commitment to fostering growth, Oriza Holdings plays a significant role in the Southeast Asian market.

Li Huaijie

Senior Partner

Liu chengwei

Chairman and CEO

Li Weiqi

Partner

Peng Liwen

Investment Director

206 past transactions

Yunshen Technology

Series A in 2025
Yunshen Technology is a manufacturing company that provides production and raw materials solutions for the semiconductor industry.

Jingrui CNC Machine Tool

Series A in 2025
Jingrui CNC Machine Tool is a private enterprise focusing on the research and production of high-end CNC machine tools and the research and development and manufacturing of intelligent flexible production lines.

ChipSine

Seed Round in 2025
ChipSine is an Integrated Circuit (IC) design company that focuses on the research and development of automotive-grade electronic control chips.

Yuanluo Technology

Series A in 2025
Yuanluo Technology is committed to providing innovative robotic solutions across multiple industries, including health, logistics, and service sectors.

Empower

Series B in 2025
Empower is an enterprise platform focused on intelligent laser manufacturing that makes lasers smart.

Jicui HiPhi

Series A in 2025
Jicui HiPhi is a enterprise incubated by the Institute of Advanced Metal Materials and Applied Technology.

Jinke Machine Tools

Series A in 2025
Jinke Machine tools specializes in manufacturing intelligent machine tools and industry solutions.

Menhai Microelectronics

Series C in 2025
Menhai Microelectronics is an integrated circuit design company engaged in the R&D and sales of MCU/SOC chips.

Insyce

Series C in 2025
Insyce creates equipment and apparatus for science. Its business strives to provide tools and technology for bio labs that monitor the environment to deliver accurate data and speedy chemical analysis while keeping lab costs down for their clients. It is dedicated to providing upper biological separation equipment and chemical analysis tools for global clients, cutting down on client operating expenses, and adding value for clients.

Northern Hemisphere Technology

Venture Round in 2024
Northern Hemisphere Technology is a high-tech company specializing in automotive-grade one-piece molded inductors. Northern Hemisphere focuses on high-performance and high-quality products, uses technology to serve customers and the market.

Jiongyi Electronics

Seed Round in 2024
Jiongyi Electronics is a developer of automotive brake products, focusing on the development of automotive brake product technology.

XellSmart

Series B in 2024
XellSmart is a company based in Minhang District, Shanghai, China, focused on developing stem cell treatment solutions for various degenerative diseases that currently lack effective clinical treatments. The firm aims to enhance disease treatment and facilitate drug discovery through innovative stem cell therapies. XellSmart is dedicated to offering large-scale and cost-effective stem cell treatment, replacement, and transplantation options, specifically targeting major conditions like Parkinson's disease. By advancing these solutions, XellSmart seeks to provide patients with viable clinical alternatives to improve their health outcomes.

Jitian Xingzhou

Seed Round in 2024
Jitian Xingzhou is a commercial aerospace company that provides optical main payloads in batches as one of its primary operations.
Suzhou Shincell New Material manufacturers environmentally friendly clean foaming materials and other lightweight materials.

Shengyin Optoelectronics

Venture Round in 2024
Shengyin Optoelectronics is a micro-nano manufacturing company that specializes in creating ornamental films for electrical appliances and portable electronics. The firm focuses on the research and development of advanced nano-printing and nano-material technologies tailored for the optoelectronics industry. Utilizing techniques such as nano-imprinting, micro-injection molding, micro-electroforming, and nano-printing, Shengyin Optoelectronics produces microstructures with exceptional resolution, reaching up to 30nm on extensive substrate surfaces. Their offerings include surface 2D and 3D structures, ultra-fine conductive lines, and integrated body structures. The company's innovations support various sectors, including consumer electronics, new energy vehicles, solar energy, and biomedical applications.

Mino Space

Series C in 2024
Mino Space is a private commercial satellite company focused on the development and application of micro-nano satellite systems. Established in 2017 and based in Beijing, the company specializes in research and development, manufacturing services, and the integration of satellite technologies. Mino Space independently designs and develops micro-nano satellite platforms and core components, including electronic communication and optical payloads. The company has significant experience in satellite communication system integration and also develops terrestrial communication terminals. Mino Space offers integrated information system solutions that leverage satellite resources for various sectors, including defense and industry. Its capabilities encompass the coordination of satellite development and overall project management, contributing to advancements in space exploration and communication technologies.

CATUG Biotechnology

Venture Round in 2024
CATUG Biotechnology specializes in the development and application of advanced biomedical technologies, particularly in the fields of gene therapy and nucleic acid drugs. The company offers comprehensive contract development and manufacturing organization (CDMO) services, addressing the entire industry chain from research and development to clinical applications and industrialization. CATUG operates R&D centers and industrialization bases located in Suzhou and Wuhan, facilitating its focus on drug research and production services.

Autolink

Series D in 2024
Autolink is involved in the automotive intelligence industry. They create a product portfolio centered on vehicle intelligence, SOA architecture, and multi-domain integration based on the central controller. They offer a single product that supports instrumentation, central control, copilot, rear seat entertainment, air conditioning control, the HUD, and surround view.

Menhai Microelectronics

Series C in 2024
Menhai Microelectronics is an integrated circuit design company engaged in the R&D and sales of MCU/SOC chips.

SmartNuclide

Series C in 2024
SmartNuclide is focused on the discovery, manufacture, and marketing of nuclear medicine pharmaceuticals, specifically in the fields of diagnostics and therapeutics for cancer treatment. The company engages in research and development of radiopharmaceutical medications, including recombinant proteins and imaging agents. By concentrating on molecular nuclear oncology, SmartNuclide aims to provide innovative biological drug products that enhance the reliability and effectiveness of cancer therapies. Through its development pathways, the company seeks to contribute significantly to the biotechnology industry by offering advanced solutions for diagnosing and treating cancer.

Zhongke Jiahe

Seed Round in 2024
Zhongke Jiahe develops compilation technology and aspires to build a universal, low-cost, high-performance fundamental software tool chain.

Tetrahedron New Energy

Venture Round in 2024
Tetrahedron New Energy is an energy technology company that specializes in the development of lithium-ion battery core material solutions.

Zhongji New Materials

Series A in 2024
Zhongji New Materials is a high-tech company focused on technology research. It produces precision grinding and polishing products.

BMSer Technoogy

Series C in 2024
Hangzhou BMSer Technology Co., Ltd., founded in 2012 and headquartered in Hangzhou, China, specializes in the development of battery management systems (BMS) with a focus on new energy solutions. The company operates under the principles of advanced technology and high quality, aiming to deliver efficient energy management and maintenance solutions. With a commitment to innovation, BMSer Technology has secured numerous intellectual property rights, including 19 invention patents, 22 utility model patents, and 24 software copyrights. The firm has developed a range of BMS products for various applications, including electric vehicles, energy storage systems, and backup power supplies. Its battery active balance management system is recognized for its innovative design and performance. BMSer Technology collaborates with major battery manufacturers and electric vehicle companies, fostering extensive partnerships within the industry. Additionally, the company has established a research and development presence in Silicon Valley, enhancing its capacity for technological advancement and market responsiveness.

Forvision

Venture Round in 2024
Forvision specializes in low-speed autonomous driving, concentrating on the development and research of intelligent ultrasonic radar products for the automotive industry. The company's innovative solutions enhance various driving functions, including parking assistance, automatic parking, remote parking, emergency braking, and blind spot monitoring. By implementing advanced intelligent driving technologies, Forvision aims to improve safety and convenience in automotive applications, positioning itself as a key player in the evolving landscape of autonomous vehicle technology.

Supermag

Series A in 2024
Suzhou Supermag Intelligent Technology Co., Ltd. (hereinafter referred to as Suci Technology) is committed to the research and development, production and sales of maglev high-speed motors. With the design authorization of magnetic levitation compressors, magnetic levitation blowers, magnetic levitation pumps, etc., it provides core components such as magnetic levitation motors, magnetic levitation bearings, magnetic levitation controllers, and displacement sensors.

Coretan Technology

Seed Round in 2023
Coretan Technology offers products for pure solid-state Flash lidar that are novel. Long range, robust anti-interference, and suitability for large-scale mass production are among the benefits of the company's products. They can give automobiles, robotics, the Internet of Things, security, and other businesses more effective sensing capabilities, improving the comfort and efficiency of human existence.

Neurodome

Seed Round in 2023
Neurodome is a manufacturer specializing in non-invasive deep brain nerve modulation technology. The company is dedicated to the research and development of innovative products that enhance neurosurgical procedures. Its offerings include wearable medical instruments, medical imaging technology, and medical information systems, all designed to improve patient outcomes and reduce the risks associated with neurosurgery. By focusing on minimally invasive solutions, Neurodome aims to advance the field of neurosurgery through its cutting-edge technology.

Wattsine

Series B in 2023
Wattsine develops and manufactures solid-state radio frequency (RF) generator systems for industrial, scientific, and medical applications. Its systems are used in heating, defrosting, drying, hazardous waste treatment, plasma actuator, construction of particle accelerator, tumor ablation, thermal therapy, and ISM applications. The company was founded in 2015 and is headquartered in Chengdu, Sichuan, China.

Sanegene Bio

Series A in 2023
Sanegene Bio is engaged in the development of RNA interference (RNAi) therapeutics aimed at addressing unmet clinical needs across various therapeutic areas. The company’s RNAi drug discovery platform focuses on effectively knocking down disease-causing genes, utilizing advanced RNA technology to ensure specific delivery of multiple RNA drugs. This innovative approach allows for targeted treatment of patients suffering from a range of conditions, including cardiovascular and metabolic diseases, immunology-related diseases, infectious diseases, and disorders affecting the central nervous system and eyes. Through its comprehensive RNAi portfolio, Sanegene Bio seeks to provide effective therapeutic solutions for challenging health issues.

Gazer

Series A in 2023
Gazer is a developer of semiconductor equipment and sensor technology, specializing in the research and innovation of sensing and control solutions for industrial automation. The company provides comprehensive sensing solutions designed to enhance quality control, safety, and service-oriented principles across various industries. Gazer's technology aims to optimize production processes and improve efficiency in sectors such as lithium-ion battery manufacturing, new energy production, consumer electronics, and healthcare. Through its focus on advanced sensing and control capabilities, Gazer addresses the critical needs of businesses seeking to enhance operational effectiveness.

Dezhi New Material

Venture Round in 2023
Dezhi New Materials is an equipment manufacturing company that focuses on the development and production of silicon carbide nano-mirror coatings and ceramic matrix composite materials. These advanced materials have diverse applications across various industries, including solar photovoltaic, aerospace, semiconductor, rail transit, chemical, and nuclear power. Dezhi New Materials aims to provide high-quality products that meet the demanding needs of industrial applications, contributing to technological advancements in these sectors.
Angitia Biopharmaceuticals is a global biotechnology company dedicated to discovering and developing innovative therapeutics for serious musculoskeletal diseases. The company focuses on researching and creating breakthrough therapies aimed at treating conditions affecting bones, muscles, and joints. By prioritizing the development of novel drugs, Angitia Biopharmaceuticals aims to improve patient outcomes and facilitate recovery from severe musculoskeletal ailments.

Juxing Technology

Angel Round in 2023
Juxing Technology is a national high-tech firm that develops intelligent, information-based teaching and management software based on artificial intelligence and virtual reality technology.

Sheng Microelectronics

Series B in 2023
Sheng Microelectronics is a driver chip design company. They engaged in creation of driver chips for amoled display screens, with an emphasis on consumer electronics goods such as smartphones and smart wearables.

Suzhou Stet Smart

Series A in 2023
Site Intelligence is a servo press control system and servo press solution provider.

HIGEC

Series A in 2023
HIGEC focuses on the research and development, production, sales and after-sales service of automobile parts.

Guoshun Laser

Seed Round in 2023
Guoshun Laser is a developer of high-power ultrafast micro-nano structure fiber lasers.

Aijie Boya

Series B in 2023
Aijie Boya is a medical instrument and magnetic solid-phase material company.

Yixi Biotech

Seed Round in 2023
Yixi Biotech is a provider of solutions for the intestinal microbiology sector, focusing on providing solutions for the intestinal microbiology sector. It mainly distributes three research and development pipelines for diabetes, depression and tumor reconstitution after tumor chemotherapy, focusing on intestinal microbes and human body. Research on health mechanisms, research on intestinal microecology and intestinal immune microenvironment interaction mechanisms and disease intervention strategies, and research and development of alternative treatment protocols, synthetic biological strains and drugs for the treatment of intestinal microbial diseases.

Common Mode Semiconductor

Series A in 2023
Common Mode Semiconductor focuses on research and development and sales of high-performance analog circuits.

Xinlu Semiconductor

Seed Round in 2023
Xinlu Semiconductor provides analog chips to compensate for the shortcomings of domestic high-end semiconductors.

SensView

Series A in 2023
SensView is a company focused on the development and production of solid-state imaging chips and detector modules. Its primary offerings include CMOS flat panel detectors, X-ray detectors like CT detectors and photon counting detectors, as well as other imaging solutions based on monocrystalline silicon technology. These products serve a range of industrial applications, highlighting SensView's commitment to innovation in imaging technology.

Kingwills New Materials

Series B in 2023
The main business of "Qingyun New Materials" is to develop, produce and sell flash-spun metamaterial Kunlun® Hypak® , which is a high-strength, waterproof and breathable special fiber material that is arranged in the form of non-woven fabrics.

Youkong Zhixing

Series A in 2023
Youkong Zhixing has focused on the development of the automotive electronic control industry. it has established three R&D bases and one production base, mainly engaged in intelligent driving system solutions, domain controllers, new energy vehicle electronic controls, automotive electronic control system solution integration, Technical services, and product support services.

SJ Semi

Series C in 2023
SJ Semi is a MEOL foundry focused on front-end wafer manufacturing and quality systems. The company specializes in bumping, Cu pillar, RDL, and testing services for 12" wafers while investing in R&D for fan-out, TSV, interposer, and 3D technologies. With over a decade of experience, SJ Semi aims to support advancements in the semiconductor market.

Muchuang

Series A in 2023
Muchuang focuses on the development of reconfigurable programming system chip application systems, chip front-end design, and testing services. Adhering to the product development line of "national secret fusion security, security fusion network, network fusion intelligence", it has two product series oriented towards information security and network control, and is determined to become a cloud, network, and terminal-oriented reconfigurable security acceleration and Smart network controller chip provider.

Menhai Microelectronics

Series B in 2023
Menhai Microelectronics is an integrated circuit design company engaged in the R&D and sales of MCU/SOC chips.

Miele Medicine

Series B in 2023
Miele is a drug research and development service provider

Haoshen Intelligence

Angel Round in 2023
Haoshen Intelligent is a manufacturer of special equipment for semiconductor devices

Neowise

Series A in 2023
XinjingZhiyuan is an immune cell therapy company focusing on solid tumors.

Eluminex Biosciences

Series B in 2023
Eluminex Biosciences is focused on researching and commercializing innovative therapies aimed at addressing unmet medical needs in ocular health. Specializing in ophthalmology and tissue regeneration, the company develops solutions based on recombinant human collagen. Its product pipeline is designed to mitigate the effects of aging and overuse on vision, thereby enhancing treatment options for healthcare providers and improving patient outcomes in the diagnosis and management of ocular conditions.

Cui Zhan Microelectronics

Series A in 2023
Cui Zhan Microelectronics is a domestic automotive-grade power device and analog integrated circuit design and sales company in the community, the company is determined to break the import monopoly, realize import substitution, and build them into a new energy automotive semiconductor industry. The business will concentrate on the difficulties and demands facing the community's new energy vehicle market, offer competitive semiconductor goods and services, and keep generating the most value for new energy vehicle buyers.

Qianjing Semiconductor

Seed Round in 2023
Qianjing Semiconductor is an enterprise that integrates semiconductor silicon carbide single crystal growth, wafer processing, and equipment development. They offer substrate products for customers in the above fields and also provide semiconductor substrate material solutions for domestic and foreign counterparts, including but not limited to wafer processing services, wafer and crystal testing services, etc.

MDS Semiconductor

Series B in 2022
MDS Semiconductor offers research and development, testing, and sales of power semiconductor devices. Their products are integrated AC-DC power supply control chips and related products. They offer advanced chip testing and finished product testing on their production lines.

Chilye

Venture Round in 2022
Chilye specializes in high-power electronic components and high-voltage connectors, focusing on the development and production of power distribution units, manual service disconnectors, charging and swapping connectors, and portable charging equipment. The company is dedicated to creating a comprehensive range of high-voltage electrical units specifically designed for alternative energy vehicles. By emphasizing technical research and development, Chilye provides clients with integrated solutions for complete vehicle systems in the electric vehicle sector.

Cell Probio

Series B in 2022
Cell Probio is a manufacturer of cell culture consumables, positioned in the R&D, production and sales of high-end biological consumables.

ITImotor

Series C in 2022
Provider of automotive technology testing services and products. The company is mainly engaged in vehicle, engine, transmission, new energy vehicle testing services and production of testing equipment, providing clients with testing technical advice.

XellSmart

Series A in 2022
XellSmart is a company based in Minhang District, Shanghai, China, focused on developing stem cell treatment solutions for various degenerative diseases that currently lack effective clinical treatments. The firm aims to enhance disease treatment and facilitate drug discovery through innovative stem cell therapies. XellSmart is dedicated to offering large-scale and cost-effective stem cell treatment, replacement, and transplantation options, specifically targeting major conditions like Parkinson's disease. By advancing these solutions, XellSmart seeks to provide patients with viable clinical alternatives to improve their health outcomes.

Listenai

Seed Round in 2022
Listen offers AI chips and industry solutions for the field of the internet of things and artificial intelligence. Their AI solutions such as offline voice interaction, in offline voice interaction, call noise reduction, offline speech synthesis, visual tracking, and scanning pen.

Finern

Series A in 2022
Finern Automation is a service provider of intelligent plant, committed to providing comprehensive solutions for the industry of advanced manufacture. Since founded in 2011, the company has established 3 research and manufacturing centers in Shanghai, Shenzhen and Wuhan in China, as well as agencies in Hong Kong, US and France, to provide customers with technical support and business consulting. Finern Automation branches out its core business into the fields of consumer electronics, vehicle electronics and new energy.

Ark Biosciences

Series D in 2022
Ark Biosciences is a biopharmaceutical company that is dedicated to the discovery and development of innovative therapeutics to address unmet medical need, especially in the area of respiratory viral infection and viral hepatitis, for global and China market. We strive to build a science-driven biopharmaceutical company that aims to be a leader in antiviral drug discovery and development. To achieve so, we aspire for the excellence of science and be innovative. We operate with a razor-sharp focus and aggressiveness with a timely and cost efficient manner. We create a healthy and rewarding work environment for employees, and seek a superior rate of return for investors and partners.

ProfoundBio

Series A in 2022
ProfoundBio is a clinical-stage biotechnology company dedicated to creating innovative antibody-based therapeutics aimed at treating cancer. Utilizing proprietary technology platforms, the company has developed a diverse pipeline of antibody-drug conjugate (ADC) candidates targeting both solid tumors and hematological malignancies. These drug candidates are currently in various stages of discovery, preclinical, and clinical development. ProfoundBio's focus is on harnessing the immune system to provide patients with more effective treatments that have the potential for curative outcomes.

Honghu Semiconductor

Series A in 2022
Honghu Semiconductor specializes in the research and development, as well as the production, of semiconductor equipment and silicon wafers. The company offers a diverse range of products, including Equipment Front End Modules, Automatic Wafer Transfer Machines, Vacuum Transfer Platforms, and various semiconductor precision components. Honghu Semiconductor provides advanced wafer automatic transfer technology, equipment solutions, and spare parts services, catering to large wafer production lines, chip manufacturers, semiconductor equipment manufacturers, and advanced packaging lines. Through its focus on localized production, the company aims to support the growing demands of the semiconductor industry.

Aijie Boya

Series A in 2022
Aijie Boya is a medical instrument and magnetic solid-phase material company.

TenNor Therapeutics

Series D in 2022
TenNor Therapeutics is a clinical-stage product development company focused on addressing unmet medical needs in infectious diseases. The company utilizes a dual-acting drug discovery platform to develop innovative treatments for a range of conditions, including Helicobacter pylori infections, prosthetic joint infections, and multidrug-resistant Gram-negative infections. Additionally, TenNor is engaged in creating therapies for diseases associated with bacterial infections and dysbiosis, particularly targeting gastrointestinal tract infections and medical device-related infections. Through its multi-targeting approach, TenNor aims to bring new therapeutic options to patients suffering from various serious infectious diseases.

Enlink Cloud

Series B in 2022
Enlink Cloud specializes in developing cloud security solutions and enterprise services, focusing on zero trust architecture to enhance information security. The company provides a range of products aimed at protecting user applications and data access, including ENLINK CASB for user application security, ENLINK SSL VPN for remote access, and iConnector, a mobile remote publishing system. Enlink Cloud's offerings are designed to meet the security needs of various sectors, including government, finance, education, and energy. By integrating application access security protection through its EnsBrain, EnsGateWay, and EnsClient components, Enlink Cloud ensures secure organizational accounts and data transmission. The company is headquartered in Nanjing, China.

Weidazhi

Series A in 2022
Weidazhi develops intelligent manufacturing comprehensive solutions. The company offers solutions for the entire line, visual measurement, core process equipment, and functional testing. Weidazhi is devoted to becoming the top producer of comparable products in the world using proprietary integration technology and manufacturing processes.

Respiree

Seed Round in 2022
Respiree is a healthcare technology company that specializes in developing AI-based breath and cardio sensors aimed at enhancing patient outcomes. The company focuses on addressing chronic respiratory diseases and mental health disorders by monitoring and detecting abnormal changes in breathing patterns and hemodynamic variability. Its platform alerts healthcare professionals to clinical deteriorations, enabling timely interventions and facilitating accurate diagnoses of cardio-respiratory conditions. By providing crucial insights into patient health, Respiree aims to improve the overall effectiveness of medical care and support better decision-making for healthcare providers.

TuringQ

Seed Round in 2022
Established in February 2021, TuringQ is committed to the research of quantum information. Through the R&D of lithium niobate on insulator (LNOI) photonic chips and femtosecond laser direct writing technology, the photon chips that enable large-scale photonic circuits integration can be prepared and an optical quantum system with a whole new level of scale and complexity can be built. At present, TuringQ has achieved leading advantages in photonic quantum chips, scientific research-grade photonic quantum computers, photonic quantum measurement and control systems, photonic quantum EDA software, and photonic quantum cloud platforms.

Chilye

Series C in 2022
Chilye specializes in high-power electronic components and high-voltage connectors, focusing on the development and production of power distribution units, manual service disconnectors, charging and swapping connectors, and portable charging equipment. The company is dedicated to creating a comprehensive range of high-voltage electrical units specifically designed for alternative energy vehicles. By emphasizing technical research and development, Chilye provides clients with integrated solutions for complete vehicle systems in the electric vehicle sector.

Blue Elephant Zhilian

Series A in 2022
Blue Elephant Zhilian is a developer of a financial privacy computing platform. The company's platform are licensed under the Ministry of Industry and Information Technology and Ministry of Public Security of China.

Common Mode Semiconductor

Seed Round in 2022
Common Mode Semiconductor focuses on research and development and sales of high-performance analog circuits.

Senses-AI

Series A in 2022
Senses-AI is a data intelligence service provider that specializes in offering advanced data and artificial intelligence solutions tailored for the banking industry. The company focuses on enhancing data assets and developing AI capabilities to facilitate intelligent risk control, marketing, operations, pricing, and analysis. By leveraging these technologies, Senses-AI aims to drive innovation and improve operational efficiency within financial institutions. Their services are designed to support the digital transformation of banks, helping them establish intelligent centers that lead the way in financial reform and modernization.

Shencong Semiconductor

Series A in 2022
Shencong Smart is a voice AI chip developer, focusing on voice application scenarios, mainly for smart homes, smart terminals, vehicles, mobile phones, wearable devices and other terminal devices. Its products have complete voice interaction functions and can realize voice processing. , voice recognition, voice broadcast and other operations, support offline voice interaction.

Virtue Diagnostics

Series B in 2022
Virtue Diagnostics is an innovative IVD company focused on infectious disease, cancer, and chronic diseases.

Atom Bioscience

Series C in 2022
Atom Bioscience is a clinical-stage biotechnology company focused on developing innovative therapies for inflammatory and metabolic diseases. The company concentrates on addressing conditions such as chronic gout, non-alcoholic steatohepatitis, diabetes, and colon cancers. By targeting the underlying mechanisms of metabolism and inflammation, Atom Bioscience aims to provide patients with more effective treatment options for these complex health issues.

CureGenetics

Series B in 2022
CureGenetics is a biotechnology company focused on developing innovative medicines and molecular diagnostics aimed at treating cancers and genetic diseases. The company specializes in research and development of gene editing technologies and delivery platforms, which are designed to provide advanced treatment solutions. By leveraging cutting-edge applications, CureGenetics seeks to address the challenges posed by these complex medical conditions through next-generation therapeutic approaches.

Accro Bioscience

Series B in 2022
Accro Bioscience research centers on the molecular mechanism of regulated cell death such as necroptosis, pyroptosis, and ferroptosis.

CATUG Biotechnology

Venture Round in 2022
CATUG Biotechnology specializes in the development and application of advanced biomedical technologies, particularly in the fields of gene therapy and nucleic acid drugs. The company offers comprehensive contract development and manufacturing organization (CDMO) services, addressing the entire industry chain from research and development to clinical applications and industrialization. CATUG operates R&D centers and industrialization bases located in Suzhou and Wuhan, facilitating its focus on drug research and production services.

Yoguang Technology

Seed Round in 2021
Seetrum is an electronics manufacturing firm that provides advanced spectroscopy chips, AI algorithms, and smart perception solutions.

QureBio

Series B in 2021
QureBio focuses on the research and development of innovative macromolecular biopharmaceuticals. Its goal is to develop new therapeutic drugs for the treatment of refractory cancer, autoimmune diseases, and metabolic diseases in China and the world to benefit patients. QureBio has multiple technology platforms for antibody drug development including phage display technology platforms and hybridoma antibodies technology platform and monoclonal antibody platform. The company was founded in 2017 and is based in Pudong District, Shanghai.

Qiyu Biotech

Series B in 2021
Qi Xiangdong, founder of Qiyu Bio, said: “Innovation is the starting and future of Qiyu Bio, and it is the core driving force of enterprise development. Qiyu Bio will use the first-class antibody technology platform to build superior biopharmaceutical pipelines and explore the field of biotherapy. A big breakthrough. With the development and improvement of the company, Qiyu will have core competitiveness in more fields.

Tianti Biotherapeutics

Series A in 2021
Tianti Biotherapeutics is a biotechnology company focused on the research and development of antibody drugs. It utilizes its proprietary Ablink platform, which facilitates extensive screening and the construction of libraries containing tens of millions of single B cells. This innovative approach enhances the efficiency of antibody development, allowing drug companies to improve the quality and effectiveness of new therapeutic antibodies. Through its advanced drug discovery capabilities, Tianti Biotherapeutics aims to contribute significantly to the field of biopharmaceuticals.

Xinlu Communication

Series A in 2021
Xinlu Communication is a chip manufacturer focusing on R&D and the sale of chips used in automotive intelligent communication and control.

Hercules Microsystems

Series B in 2021
Jingwei Qili is a developer of hybrid programmable computing chips. The company's products are mainly FPGA chip series products, as well as development boards and kits, etc., which can be applied to the field of artificial intelligence. At the same time, the company's business also includes providing users with testing and maintenance Circuits and other services.

Xinge

Series B in 2021
Xinge is a company dedicated to the field of intelligent manufacturing. Recently announced the completion of over 100 million yuan of B round of financing. This round of financing was led by Yuanhe Puhua, followed by China Merchants Securities, Amoeba Capital, and old shareholder Linxin Capital. Sina Capital served as the exclusive financial adviser. The financing will further support Xinge's research and development in the machine vision industry, and accelerate the company's team building and market layout.

Qiaochu

Series A in 2021
Qiaochu Archives is a digital intelligence archives management solution provider. The company focuses on digital intelligence archives management. It conducts scientific, intelligent, and data-based management of the entire life cycle of archives from sorting to permanent preservation or destruction to create a higher Level of comprehensive management services for archive information security.

Skysys

Series A in 2021
Skysys is a company specializing in data acquisition and analysis services for drones, particularly focusing on unmanned aerial vehicles (UAVs). It offers comprehensive solutions that include automatic scheduling, data acquisition, and analysis, which help users enhance location accuracy and improve data reliability. The company aims to become a leader in the collection and analysis of data related to civil rotary aircraft in China. In addition to its core services, Skysys is developing advanced artificial intelligence for the automatic operation of rotorcraft drones, with applications extending to various industries, including gold mining.

Axbio

Series B in 2021
Axbio Inc. is a biotechnology company based in Shenzhen, China, specializing in genetic sequencing technology and diagnostic solutions. Founded in 2016, the company develops a variety of products, including genome extraction kits for stool, blood, saliva, and bacteria. Axbio also provides advanced sequencing systems, disposable biochips, and reagents. The company is focused on creating high-throughput molecular diagnostics through its novel microfluidic Bio-CMOS platform, which supports both low-cost handheld devices for bedside diagnostics and fully automated laboratory instruments. This technology enables applications such as early cancer screening, rapid pathogen detection, and drug development. Currently, Axbio operates in stealth mode as it continues to innovate within the field.

Global Power Technologies

Series D in 2021
Global Power Technology is a high-tech company that is dedicated to offering SiC-based power devices and system solutions.

SJ Semi

Series C in 2021
SJ Semi is a MEOL foundry focused on front-end wafer manufacturing and quality systems. The company specializes in bumping, Cu pillar, RDL, and testing services for 12" wafers while investing in R&D for fan-out, TSV, interposer, and 3D technologies. With over a decade of experience, SJ Semi aims to support advancements in the semiconductor market.

Senfeng Yiliao

Series A in 2021
Senfeng Yiliao engages in innovating medical metal material technology.

Peifeng Tunan

Series A in 2021
Peifeng Tunan is an enterprise that offers Design Technology Co-Optimization (DTCO) one-stop "software + service" complete solutions for manufacturing of full process EDA software.

Luoan

Series B in 2021
Luoan Technology specializes in industrial cyberspace security, providing a range of products and solutions aimed at enhancing safety and security for various industries. The company offers services that include security management, risk assessment, penetration testing, emergency response, safety training, and compliance testing. Its clientele encompasses sectors such as petrochemical, equipment manufacturing, power, metallurgy, and chemicals. By focusing on these industries, Luoan Technology aims to help businesses safeguard their operations, ensuring the protection of both workers and products.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.